News

Article

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

The Eye Care Network adds a longstanding, CME-certified to its live event programming.

MJH Life Sciences acquires EnVision Summit - ©dennisvdwater

Image credit: Adobe Stock/dennisvdwater

MJH Life Sciences, parent company of Ophthalmology Times, has acquired The EnVision Summit. The meeting, held annually in Puerto Rico, combines an innovative CME-certified education program with a first-class family experience.

The summit will be hosted as a CME-certified conference within the Physicians’ Education Resource® legacy portfolio, supported by the care network brands Ophthalmology Times and Optometry Times. MJH Life Sciences noted in a press release that the acquisition aligns with its long-term growth strategy supported by a strategic partnership with BDT & MSD Partners.

The holistic approach to the summit includes age-appropriate activities for participants' family members, including children. In 2024, the EnVision Summit debuted an optometry track concurrent with the existing ophthalmology sessions.

Bonnie An Henderson, MD, the EnVision Summit director and cofounder, expressed enthusiasm about the future of the summit under MJH Life Sciences’ leadership. Henderson, President and CEO of global nonprofit HelpMeSee, as well as a past president of the American Society of Cataract and Refractive Surgery.

“I am thrilled about the possibilities that this acquisition brings for the EnVision Summit,” Henderson said. “With the resources and expertise of MJH Life Sciences, we will be able to elevate our educational offerings to new heights, ensuring that eye care professionals worldwide have access to the most current and comprehensive information in multiple channels to better serve their patients. I look forward to continuing as the Program Director to maintain the excellence of the content and faculty.”

Mike Hennessy Jr., president and CEO of MJH Life Sciences, commented on the news, describing it as a continuation of MJH Life Sciences’ mission. “As we continue to expand our commitment to education in the eye care space, the acquisition of EnVision Summit allows us to build on the strong foundation we’ve established with our leading brands,” he said. “The summit and its hundreds of loyal attendees will benefit not only from our expertise in providing engaging educational experiences on cutting-edge topics, but also from new and expanded opportunities to help them address the rapidly evolving ophthalmic landscape.”

The upcoming EnVision Summit is scheduled for February 14-17, 2025, at the Caribe Hilton, San Juan, Puerto Rico

Ophthalmology Times has previously covered the EnVision Summit. In our archives, we have an interview with Henderson prior to the 2024 Summit, as well as conversations with speakers on key takeaways from their presentations as well as with attendees on what makes the meeting so special.

To learn more and to register for the event, please visit www.envisionsummit.org.

Reference:
  1. MJH Life Sciences® acquires EnVision Summit, expands leadership in eye care education. MJH Life Sciences. Press release. Accessed October 9, 2024.
Related Videos
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
© 2025 MJH Life Sciences

All rights reserved.